Group items tagged

MaRS Discovery District has selected Alexandria Real Estate Equities Inc, the largest publicly traded U.S. life science realty company, to develop a 900,000 square foot high-rise office and laboratory complex that will include an of the atrium in the MaRS building. Jun 27, 2007

MaRS Discovery District has selected Alexandria Real Estate Equities Inc, the largest publicly traded U.S. life science realty company, to develop a 900,000 square foot high-rise office and laboratory complex that will include an of the atrium in the MaRS building.

Peter Singer, National Post looks at how we open the innovative sectors of our economy to the global markets and how Canada can assist developing countries to accelerate the commercialization of their own products to tackle their own problems. The MaRS Centre is helping to tackle these problems by bringing together science, business and capital.

Peter Singer, National Post looks at how we open the innovative sectors of our economy to the global markets and how Canada can assist developing countries to accelerate the commercialization of their own products to tackle their own problems. The MaRS Centre is helping to tackle these problems by bringing together science, business and capital. Nov 21, 2007

Judy Steed, Reporter, The Star, reports about MaRS's first anniversary and talks about the MaRS story where extraordinary developments are commercialized into lead edge research.

Judy Steed, Reporter, The Star, reports about MaRS's first anniversary and talks about the MaRS story where extraordinary developments are commercialized into lead edge research. Feb 8, 2008

The Canadian Institutes of Health Research (CIHR) publishes yearly reports on Canadians' research dollars at work. In addition to reporting on specific health care 'research successes' and developments, the site links to regional profiles (Atlantic Canada, Quebec, Ontario, The Prairies, and British Columbia). The 2006-2007 editions are now up.\n\nCIHR's 2-page Commercialization report (PDF) for 2006-2007 reveals Canada's Innovation Index for the year as well as the country's shift towards investing in new companies and capacities. CIHR's commercialization strategy includes research, talent, capital, and linkages.

Lisa Torjman, Associate, Development for Social Entrepreneurship and Innovation Programs at MaRS. Mention of Torjman's role at MaRS and what the SiG @ MaRS program is about. Mention of Torjman's most recent project "Net Change" - a week-long event exploring social technology and social change.

The groundswell of geothermal interest among builders, developers and individual homeowners all over the GTA is mainly because it's what "green" venture capitalist and MaRS Advisor Tom Rand calls "low hanging fruit" on the energy tree - easy to pluck and very cheap in the long run. Tom talks about the opportunities available to enterprising, innovative businesses.

MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs.

MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. Feb 6, 2009

Several high-rise sites in the downtown core have been temporarily shut down as the developers wait for the economic climate to improve. Mention of MaRS Discovery Districts' expansion on hold.

The symposium, Entrepreneurship & Commercialization in Biomedical Science, is being held on Thursday, May 14, which marks the 50th anniversary of both York University and The Gairdner Foundation. At this symposiums they will address the problem that Canadian researchers expertise to need to do in developing drugs and vaccines to address pressing medical needs. Mention of Susan Smith as a Board Member of MaRS Innovation.

Consider the two faces of the global innovation movement. Company A, having grown through acquisition, produces multiple brands for multiple markets and operates a worldwide network of research and product development centers. Each of its R&D sites was initially responsible for its own brands and local market, but with globalization these distinctions have lost their importance. Company B, on the other hand, was built largely through internal growth and has two global brands. It operates one primary R&D center supported by a handful of special-purpose sites around the world. This comparatively sparse network has helped Company B win wide admiration for the efficiency of its engineering. Because expanding the number of nodes in a network exponentially increases its complexity, it is not surprising that Company A's R&D structure is more expensive to operate. Company A has considered closing some sites, but has resisted doing so because it fears losing capabilities and insights, and roiling local markets. Meanwhile, incremental budget cuts have chipped away at engineer and supplier morale. Having built its network to maximize the value associated with market access, it is now forced to manage the network for cost. Most global innovation networks look like Company A's - and suffer the same problems. Company B's R&D structure is clearly more productive, but it is not necessarily ideal either. Its network might be too compact, limiting access to knowledge that could maximize performance. Thus, to identify principles and practices for creating a truly well-designed innovation network, Booz Allen Hamilton and INSEAD, the international business school, surveyed R&D leaders in 186 companies from 17 industry sectors in 19 nations in 2005. The survey results, and our own experience, suggest one central truth: Organizations benefit when they configure their innovation networks for cost and manage them for value.

A look at Canadian immigrants who started a business and are incubating at the MaRS Centre. KCT and Clera, MaRS Tenants tell their stories. Jan/Feb 2009

A look at Canadian immigrants who started a business and are incubating at the MaRS Centre. KCT and Clera, MaRS Tenants tell their stories.

Canada's lead federal funding agency for health research, this website collects funding news and developments from all over Canada, including: * Funding opportunities * How to apply for funding * Funding enquiries

Canada's lead federal funding agency for health research, this website collects funding news and developments from all over Canada, including:\n\n * Funding opportunities\n * How to apply for funding\n * Funding enquiries

MaRS Innovation (MI) and the Centre for Drug Research and Development (CDRD) are pleased to announce that they have entered into an agreement to collaborate on projects of mutual interest with a goal to advance and commercialize early-stage health-related discoveries. Dec 15, 2009

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) announced an investment of $1 million towards the development of two new promising cancer therapies. OncoTek Drug Delivery Inc (a subsidiary of Receptor Therapeutics) is one of the recipients.

Carly Weeks, a Globe and Mail reporter interviews Dr. Calvin Stiller. "Dr. Stiller was named a recipient of a prestigious Canada Gairdner Award and always had a dire need to fix the imbalance of research and commercial development in the country's life sciences. He says he has always had an entrepreneurial spirit, which inspired him to work with colleagues to create centres such as the Toronto-based MaRS Discovery District."

The CleanTech What's New with Wind? Seminar was held on May 12, and sponsored by Ogilvy Renault, Deloitte and the Toronto centre for innovation MaRS Discovery District. Panelists at this event believe that developers of wind power technologies will be more reliant on third parties to provide the domestic content they have been contracted to provide.

As stated in Product Design and Development "Researchers from the University of Toronto (U of T), the King Abdullah University of Science & Technology (KAUST) and Pennsylvania State University (Penn State) have created the most efficient solar cell ever made based on collodial-quatum-dots...a technology licensing agreement has been signed by U of T and KAUST, brokered by MaRS Innovations (MI), which will will enable the global commercialization of this new technology." 

Canada is seriously committed to phasing out all coal-fired electricity generation within five years and to becoming North America's leading green jurisdiction. To help to do this Ontario has passed a Green Energy Act with strong incentives . Tom Rand, who leads an advisory service for companies wishing to develop a stake in clean technology, at the non-profit MaRS headquarters in downtown Toronto, agrees on the importance of this 'right to connect'.

The Sunday Edition of the CBC Radio Show has posted a podcast of their interview with Nobel Peace Prize-winning economist Muhammad Yunus. About Muhammad Yunus: After the great famine of 1974 the Grameen Bank of Bangladesh was founded by Muhammad Yunus. This bank was the first in an innovative approach to moneylending now known as "micro-banking". The Grameen Bank makes loans to the poor, and functions as both a business and a social development program (CBC, The Sunday Edition).